Brief: Mirum Pharmaceuticals Q1 Basic EPS USD -0.54
08/05/2024 21:02
May 08 (Reuters) - Mirum Pharmaceuticals Q1 operating expenses USD 95.69 million. * Q1 net income USD -25.279 million * Q1 product sales USD 68.917 million * Q1 operating income USD -26.468 million
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX